Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
MINNEAPOLIS, Feb. 02, 2016 -- Urologix, Inc. (OTC Pink:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, announced today that as of the close of business on January 29, 2015 substantially all of the operating assets of Urologix, Inc. including the Urologix name were surrendered to a secured creditor and subsequently purchased by a private company to partially address the secured debt owed to the secured creditor. The sale of Urologix’s operating assets was contemplated by a forbearance agreement entered into with the secured creditor on December 7, 2015. The buyer will operate the existing business through an entity named “Urologix, LLC.”
The transaction will enable Urologix, LLC to provide urology customers and their patients with both Cooled ThermoTherapy and Prostiva RF Therapy products and services to treat BPH in the comfortable setting of a urologist’s office.
Concurrent with these events, Urologix, Inc. was renamed 21st North Inc. Immediately following the transaction, 21st North Inc. has no operations and has commenced an orderly wind down. Accordingly, 21st North intends to submit a proposal to its shareholders in the ensuing weeks to approve a plan of dissolution. The Company will not be making liquidating distributions to shareholders at any time.
Contact Information: Greg Fluet [email protected]
